105 related articles for article (PubMed ID: 9495264)
1. Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans.
Barletta G; Lazzeri C; Vecchiarino S; Del Bene R; Messeri G; Dello Sbarba A; Mannelli M; La Villa G
Hypertension; 1998 Mar; 31(3):802-8. PubMed ID: 9495264
[TBL] [Abstract][Full Text] [Related]
2. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep.
Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
Am J Physiol; 1995 Jan; 268(1 Pt 2):R201-7. PubMed ID: 7840321
[TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic peptide does not affect plasma and urinary adrenomedullin in man.
Lazzeri C; Tosti Guerra C; Vecchiarino S; Barletta G; Stefani L; Bandinelli R; Franchi F; La Villa G
Clin Physiol; 1999 Jan; 19(1):68-75. PubMed ID: 10068868
[TBL] [Abstract][Full Text] [Related]
4. The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction.
Lainchbury JG; Richards AM; Nicholls MG; Hunt PJ; Ikram H; Espiner EA; Yandle TG; Begg E
Hypertension; 1997 Sep; 30(3 Pt 1):398-404. PubMed ID: 9314423
[TBL] [Abstract][Full Text] [Related]
5. C-type natriuretic peptide in chronic renal failure and its action in humans.
Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K
Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
[TBL] [Abstract][Full Text] [Related]
7. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
Cargill RI; Struthers AD; Lipworth BJ
Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of physiological increments of brain natriuretic peptide in humans.
La Villa G; Stefani L; Lazzeri C; Zurli C; Guerra CT; Barletta G; Bandinelli R; Strazzulla G; Franchi F
Hypertension; 1995 Oct; 26(4):628-33. PubMed ID: 7558223
[TBL] [Abstract][Full Text] [Related]
9. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension.
Lazzeri C; Franchi F; Porciani C; Fronzaroli C; Casini Raggi V; De Feo ML; Mannelli M; Cersosimo RM; La Villa G
Am J Hypertens; 1995 Aug; 8(8):799-807. PubMed ID: 7576396
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.
Rosenbaek JB; Al Therwani S; Jensen JM; Mose FH; Wandall-Frostholm C; Pedersen EB; Bech JN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F378-F387. PubMed ID: 28490529
[TBL] [Abstract][Full Text] [Related]
12. Renal and vascular effects of C-type and atrial natriuretic peptides in humans.
Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S
Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man.
La Villa G; Fronzaroli C; Lazzeri C; Porciani C; Bandinelli R; Vena S; Messeri G; Franchi F
J Clin Endocrinol Metab; 1994 May; 78(5):1166-71. PubMed ID: 8175974
[TBL] [Abstract][Full Text] [Related]
14. Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans.
De Feo ML; La Villa G; Lazzeri C; Tosti-Guerra C; Becorpi A; Pupilli C; Mannelli M
Hypertension; 1997 Jan; 29(1 Pt 1):70-4. PubMed ID: 9039083
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure.
Molina CR; Fowler MB; McCrory S; Peterson C; Myers BD; Schroeder JS; Murad F
J Am Coll Cardiol; 1988 Jul; 12(1):175-86. PubMed ID: 2967855
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular, endocrine, and renal effects of urodilatin in normal humans.
Bestle MH; Olsen NV; Christensen P; Jensen BV; Bie P
Am J Physiol; 1999 Mar; 276(3):R684-95. PubMed ID: 10070128
[TBL] [Abstract][Full Text] [Related]
17. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
[TBL] [Abstract][Full Text] [Related]
18. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
20. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
Palmer SC; Prickett TC; Espiner EA; Yandle TG; Richards AM
Hypertension; 2009 Sep; 54(3):612-8. PubMed ID: 19620509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
